Guduchi Rasayana and Shamaoushadhi for Primary Hypothyroidism(Medoroga)

Phase 3

• Conditions: Health Condition 1: E039- Hypothyroidism, unspecified

• Registration Number: CTRI/2024/02/063122
• Lead Sponsor: All India Institute of Ayurveda

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 4 March 2024

Recruitment & Eligibility

• Status: ot Yet Recruiting
• Sex: Not specified
• Target Recruitment: 0

Inclusion Criteria

Age 21 to 50 Years

TSH Levels more than or equal to 5.6mIU/L to less than or equal to 10mIU/L patients will be included only after 8 weeks of stable thyroxine dosage who followed the regimen in the correct way.

Exclusion Criteria

EXCLUSION CRITERIA:

•Patient having TSH level greater than >10.0 mIU/ L.

•Recent/post thyroid surgery or radio-iodine (within 12 months).

•Uncontrolled blood sugar (FBS-125 mg/dl PPBS- 180 mg/dl) hypertension SBP >140, DBP >90 mm of Hg

•Recent acute coronary syndrome, including myocardial infarction or unstable angina.

•Suffering from diseases like HIV, tuberculosis, encephalopathy, goiter, other endocrine disorders (except Type 2 DM) and other autoimmune disorders.

•Pregnancy, lactation.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Change in Free TFTTimepoint: Patients will be called for assessment at 0th day, 33rd day, 63rd day and 93rd day during the intervention and follow up with a window period of 7 days

Secondary Outcome Measures

Name	Time	Method
•Changes in the inflammatory markers. <br/ ><br>•Changes in sign and symptoms. <br/ ><br>•Change in quality of life.Timepoint: Patients will be called for assessment at 0th day, 33rd day, 63rd day and 93rd day during the intervention and follow up with a window period of 7 days.